|
|
Blocked cholecalciferol and dihydrotachysterol 3 derivatives
We have found that cholecalciferol and dihydrotachysterol.sub.3 and their derivatives may be metabolically blocked by the presence of a halo or O-C.sub.1-5 alkyl ...
|
|
|
4-[(Carboxyl- and sulfamyl-substituted alkyl)-amino] benzoic acids and analogs
OF THE INVENTION The compounds of the invention are new and novel 4-[(carboxyl- and sulfamyl-substituted alkyl)amino]benzoic acids and analogs which have ...
|
|
|
Vaccine production
What is claimed is: 1. In a process for the controlled manufacture of vaccines wherein cells are grown in a glucose containing nutrient medium and infected with a virus, ...
|
|
|
Method of fermenting brewer's wort
We claim: 1. The method of preparing an alocholic beverage, comprising the steps of preparing an aqueous fermentable substrate containing fermentable carbohydrates and ...
|
|
|
Treatment of hemorrhagic shock
I claim: 1. A method of treating shock in humans to reverse the same and elevate blood pressure which comprises intravenously administering to a patient in need thereof ...
|
|
|
Compositions comprising alkylpolysaccharide detergent surfactant
What is claimed is: 1. A homogeneous granular detergent composition comprising: (1) from about 2% to about 30% of alkylpolysaccharide detergent surfactant having the ...
|
|
|
Process for the preparation of a mixture of sucrose oxidation products and the use thereof
We claim: 1. A process for the preparation of a mixture of sucrose oxidation products which comprises a salt of sucrosetricarboxylic acid comprising reacting sucrose ...
|
|
|
Process for making a high density detergent composition from starting detergent ingredients
OF THE PREFERRED EMBODIMENT The present process is used in the production of low dosage detergent agglomerates directly from starting detergent ingredients rather than ...
|
|
|
Aqueous alkaline composition
OF THE INVENTION In Formula I a is from 2.5 to 7, preferably from 3 to 6.5, more preferably from 3.5 to 6, most preferably, a is higher than b. In Formula II c is from 0...
|
|
|
Stereospecific keto reduction of bicyclooctandione-carboxylic acid esters by microorganisms
What is claimed is: 1. A process for the production of a 3.alpha.-hydroxy prostacyclin intermediate product of the formula (+)-I ##STR7## wherein A is the radical >CH-...
|
Molecular Biology 
